Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 72789-115

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 72789-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789115 Label (72789115)

This is a warning label for a medication called Cyclobenzaprine, which may cause drowsiness and should be used with caution while driving or performing tasks needing mental alertness. The text includes dosage and storage instructions, as well as information about the lot and expiration date. The label also warns to keep the medication out of the reach of children and to call a doctor for medical advice about side effects. It provides a phone number to report side effects to the FDA. The package contains 20 film-coated tablets of 5mg each. The text includes a GTIN and SNO, and mentions the manufacturer as PD-Rx Pharmaceuticals Inc., located in Oklahoma City.*

FDA Label Image

Structural Formula For Cyclobenzaprine. (Cyclobenzaprine 1)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.